EFFECTIVENESS AND SAFETY OF USE OF BIGUANIDE AND SULFONYLUREA DRUGS WITH HISTOPATHOLOGICAL ANALYSIS AND PARAMETERS OF THE KIDNEY, LIVER AND PANCREAS IN ALLOXAN-INDUCED RATS
DOI:
https://doi.org/10.22159/ijap.2024v16s5.52469Keywords:
Diabetes mellitus, Metformin, Glimepiride, Glibenclamide, AlloxanAbstract
Objective: There are several drugs used as first-line in the treatment of type 2 diabetes with different mechanisms of action, such as metformin, glimepiride, and glibenclamide. The mechanism action of the drugs through stimulation and increased insulin sensitivity. This mechanism can have side effects on the organs excreting the drug. The aim of this study was to compare the effectiveness and safety of the three drugs in alloxan-induced rats.
Methods: A total of 15 rats were divided into five groups with each group consisting of three rats: Normal Control (NC), Induced Control (DC), Metformin 9 mg/kgBW, Glimepiride 1 mg/kgBW, and Glibenclamide 5 mg/KgBW. Fasting Blood Glucose (FBG) levels, Blood Urea Nitrogen (BUN), Creatinine Serum (SCr) and Serum Glutamate Pyruvate Transaminase (SGPT) were obtained. Data analysis using ANOVA and a post-hoc test.
Results: The results show that in comparison of the three anti-diabetic drugs, glibenclamide causes the highest damage to the pancreas and liver. Meanwhile, glimepiride provides the safest results for the kidneys, and metformin is safest for the liver.
Conclusion: The result showed that the drug glibenclamide caused the highest damage to pancreatic cells and glimepiride gave the greatest decrease in blood glucose levels, but the use of glimepiride for 14 d was safer for use than for glibenclamide for kidney parameters.
Downloads
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62-9. doi: 10.2337/dc10-S062, PMID 20042775.
Idacahyati K, Wulandari WT, Gustaman F, Nurdianti IL. Activity nanokirinyuh (Chromolaena odorata) leaves extract in alloxan induced diabetic rats. Int J App Pharm. 2021;13(4):220-2. doi: 10.22159/ijap.2021.v13s4.43863.
Darusman F, Rusdiana T, Sopyan I, Yuliar NF, Aryani R. Bioequivalence of metformin as an oral antidiabetic: a systematic review. Int J App Pharm. 2023;15(6):76-81. doi: 10.22159/ijap.2023v15i6.49142.
Lipscombe L, Booth G, Butalia S, Eurich Bsp DT, Goldenberg R, Khan N. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in canada: pharmacologic glycemic management of type 2 diabetes in adults. Can J Diabetes 2018;42:S88-103.
Filion KB, Douros A, Azoulay L, Yin H, YU OH, Suissa S. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: a population-based cohort study. Br J Clin Pharmacol. 2019;85(10):2378-89. doi: 10.1111/bcp.14056, PMID 31276600.
Basit A, Riaz M, Fawwad A. Glimepiride: evidence-based facts trends and observations (GIFTS). Vasc Health Risk Manag. 2012;8:463-72. doi: 10.2147/HIV.S33194, PMID 23028231.
Soelistijo S. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di indonesia 2021. Glob Initiat Asthma. 2021;46.
Wahyuni AS, Hakim L, Nurrochmad A, Astuti P. The sinergistic effect of black rice bran extract and glibenclamide on protecting renal hepatic and pancreatic cells in alloxan-induced rats. IJPR. 2020;12(1):509-17. doi: 10.31838/ijpr/2020.12.01.113.
Sujono TA, Kusumowati ITD. Antidiabetic effect of cashew (Anacardium occidentale l.) leaves ethanol extract in diabetic rats induced by alloxan pros 1st Annu Pharm Conf. FMIPA UNS; 2020.
Ambade VN, Sharma YV, Somani BL. Methods for estimation of blood glucose: a comparative evaluation. Med J Armed Forces India. 1998;54(2):131-3. doi: 10.1016/S0377-1237(17)30502-6, PMID 28775446.
Muhtadi PAU, Primarianti AU. Antidiabetic activity of durian (Durio Zibethinus murr.) and rambutan (Nephelium lappaceum L.) fruit peels in alloxan diabetic rats. Procedia Food Sci. 2015;3:255-61. doi: 10.1016/j.profoo.2015.01.028.
Sari N, Wahyuni AS. Effect of black rice bran extract to decrease glucose level of diabetic rats. Pharmacon. 2017;18:8-12.
Rompas IZ, Bodhi W, Lebang JS. Antihyperglycemic effectiveness test of ethanol extract of red gedi leaves (abelmoschus manihot l. medik) against white rats (rattus norvegicus) wistar strain induced by alloxan. Pharmacon. 2021;10:940-7.
Mondol D, Islam MN, Biswas S, Jodder P, Sana S, Saleh MA. Investigation of the synergistic effect of glimepiride and rosuvastatin on alloxan-induced diabetic rat. J Diabetes Metab Disord. 2020;19(2):1415-22. doi: 10.1007/s40200-020-00662-6, PMID 33553033.
Rai A, Eapen C, Prasanth VG. Interaction of herbs and glibenclamide: a review. ISRN Pharmacol. 2012;2012:659478. doi: 10.5402/2012/659478, PMID 22844612.
Singh S, Verma N, Karwasra R, Kalra P, Kumar R, Gupta YK. Safety and efficacy of hydroalcoholic extract from Lawsonia inermis leaves on lipid profile in alloxan-induced diabetic rats. AYU. 2015;36(1):107-12. doi: 10.4103/0974-8520.168999, PMID 26730149.
Kale VP, Patel SG, Gunjal PS, Wakchaure SU, Sundar RS, Ranvir RK. Effect of repeated freezing and thawing on 18 clinical chemistry analytes in rat serum. J Am Assoc Lab Anim Sci. 2012;51(4):475-8. PMID 23043814.
Brackett CC. Clarifying metformins role and risks in liver dysfunction. J Am Pharm Assoc. 2010;50(3):407-10. doi: 10.1331/JAPhA.2010.08090, PMID 20452916.
Nuralifah N, Muhammad Fitrawan LO, Parawansah P, Trisetya M. Histopathology of the pancreatic organ of type 2 Dm rats given ethanol extract of red gedi leaves (Abelmoscus Manihot L Medik). J Syifa Sci Clin Res. 2022;4(1):141-51. doi: 10.37311/jsscr.v4i1.13566.
Ioannidis I. Diabetes treatment in patients with renal disease: is the landscape clear enough. World J Diabetes. 2014;5(5):651-8. doi: 10.4239/wjd.v5.i5.651, PMID 25317242.
Kleen M, Kangas H, Laine C. Chemical characterization of mechanical pulp fines and fiber surface layers. Nord Pulp Pap Res J. 2003;18(4):361-8. doi: 10.3183/npprj-2003-18-04-p361-368.
Rambiritch V, Maharaj B, Naidoo P. Glibenclamide in patients with poorly controlled type 2 diabetes: a 12 w, prospective single center open label dose-escalation study. Clin Pharmacol. 2014;6:63-9. doi: 10.2147/CPAA.S54809, PMID 24741335.
Candasamy M, Murthy TE, Gubiyappa KS, Chellappan DK, Gupta G. Alteration of glucose-lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models. J Basic Clin Pharm. 2014;5(3):62-7. doi: 10.4103/0976-0105.139728, PMID 25278668.
Cicih A, Aligita W, Susilawati E. A review: the pharmacokinetics and pharmacodynamics of metformin herb interactions. JIF. 2022;18(1):13-25. doi: 10.20885/jif.vol18.iss1.art2.
Yusuf NA, Abdassah M, Sopyan I, Mauludin R, Joni IM, Chaerunisaa AY. Improved characteristics of glibenclamide as transethosome vesicular system: physicochemical solubility and in vitro permeation study. Int J App Pharm. 2024;16(1):172-85. doi: 10.22159/ijap.2024v16i1.49245.
Published
How to Cite
Issue
Section
Copyright (c) 2024 ARIFAH S. WAHYUNI, FIRDA AYU F. RAHMAWATI, DISKI W. WIJIANTO, RETNO A. UMNIYYAH
This work is licensed under a Creative Commons Attribution 4.0 International License.